🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: mirabegron 50 mg matching placebo

Found 15 matching trials

A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder

PHASE3

The purpose of this study was to examine how well the combination of two me...

Status

Completed

Location

Site US10049

Start Date

2014-03-17

Trial ID

NCT02045862

Treatments Being Tested

Solifenacin succinate Mirabegron Placebo to match solifenacin Placebo to match mirabegron

A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)

PHASE3

The purpose of this study was to see if adding a new type of medication rec...

Status

Completed

Location

Genova Clinical Research

Start Date

2013-07-10

Trial ID

NCT01908829

Treatments Being Tested

mirabegron 25 mg mirabegron 50 mg solifenacin 5 mg solifenacin 10 mg mirabegron 25 mg matching placebo mirabegron 50 mg matching placebo solifenacin 5 mg matching placebo solifenacin 10 mg matching placebo

A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

PHASE3

The study is intended to test the efficacy, safety and tolerability of two ...

Status

Completed

Location

Multiple Locations

Start Date

2008-03-28

Trial ID

NCT00662909

Treatments Being Tested

Mirabegron Placebo

Mirabegron and Oxybutynin Safety and Efficacy Trial in Spinal Cord Injury

PHASE2

The purpose of this research study is to determine the effectiveness and sa...

Status

Unknown

Location

Kessler Institute for Rehabilitation

Start Date

2019-04-03

Trial ID

NCT03187795

Treatments Being Tested

Oxybutynin Chloride IR Mirabegron

Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

PHASE3

The study is intended to test efficacy, safety and tolerability of two dose...

Status

Completed

Location

Multiple Locations

Start Date

2008-04-28

Trial ID

NCT00689104

Treatments Being Tested

Mirabegron Tolterodine Placebo to Mirabegron Placebo to Tolterodine

A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

PHASE4

The purpose of the study was to assess the efficacy, safety, and tolerabili...

Status

Completed

Location

Site US01009

Start Date

2016-06-13

Trial ID

NCT02757768

Treatments Being Tested

Mirabegron Placebo Tamsulosin Hydrochloride

A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)

PHASE4

The primary objective of the study was to investigate the efficacy of mirab...

Status

Completed

Location

Site JP81046

Start Date

2016-01-25

Trial ID

NCT02656173

Treatments Being Tested

Mirabegron Placebo Tamsulosin

Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

PHASE3

The study is intended to test the safety, tolerability, efficacy of two dos...

Status

Completed

Location

Multiple Locations

Start Date

2008-04-25

Trial ID

NCT00688688

Treatments Being Tested

Mirabegron Tolterodine Placebo to Mirabegron Placebo to Tolterodine

Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)

PHASE4

The purpose of this study was to assess the efficacy, safety and tolerabili...

Status

Completed

Location

Site US00066

Start Date

2014-10-07

Trial ID

NCT02216214

Treatments Being Tested

Mirabegron Placebo

A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder

PHASE2

The purpose of this study is to examine how well two medicines in combinati...

Status

Completed

Location

BY37101

Start Date

2011-03-29

Trial ID

NCT01340027

Treatments Being Tested

Mirabegron Solifenacin succinate Placebo

Previous Next